Clinical trial NCT04945551: Cellular Adaptations to Training in Patients With Type 2 Diabetes
Official title: Cellular Adaptations to Training in Patients With Type 2 Diabetes
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Diabetes Mellitus, Type 2
Keywords: Diabetes Mellitus, Type 2
Aerobic exercise
Insulin sensitivity
Lead sponsor: University of Copenhagen
Sponsor class: OTHER
Collaborators: name: Novo Nordisk A/S
First posted: 2021-06-30
Enrollment: 30
Sex: ALL
Minimum age (years): 40
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Thirty obese patients with (n=15) and without (n=15) type 2 diabetes will be included in the study. Both groups will undergo a 12-week aerobic exercise training intervention.
Primary purpose: BASIC_SCIENCE

Brief summary: Physical training can improve metabolic health in patients with insulin resistance and/or type 2 diabetes (T2D). The cellular and molecular changes underlying the improvements in metabolic health are multi-factorial and only partly understood, but most likely involve adaptation at a multi-organ level that includes improvements in skeletal muscle glucose uptake and adipose tissue insulin sensitivity.

The aim of this project is to study the transcriptional differences in skeletal muscle and adipose tissue at baseline and after a 3-month physical training program in obese patients with and without T2D and to use this information to identify novel therapeutic targets for improvement of glucose disposal and insulin sensitivity in patients with T2D.

Thus, the investigators aim to find answers to the question: What is the mechanism behind the effect of physical activity on insulin sensitivity in type 2 diabetes?

Detailed description: Background and aim

Physical training can improve metabolic health in patients with insulin resistance and/or type 2 diabetes (T2D). The cellular and molecular changes underlying the improvements in metabolic health are multi-factorial and only partly understood, but most likely involve adaptation at a multi-organ level that includes improvements in skeletal muscle glucose uptake and adipose tissue insulin sensitivity.

The literature on the effects of an acute bout of exercise on glucose uptake in skeletal muscle is large, but so far, there is a lack of studies investigating the specific molecular basis for the insulin sensitizing effect of regular physical training.

The aim of this project is to study the transcriptional differences in skeletal muscle and adipose tissue at baseline and after a 3-month physical training program in obese patients with and without T2D and to use this information to identify novel therapeutic targets for improvement of glucose disposal and insulin sensitivity in patients with T2D.

Thus, the investigators aim to find answers to the question: What is the mechanism behind the effect of physical activity on insulin sensitivity in type 2 diabetes?

Methods

Thirty obese patients with (n=15) and without (n=15) type 2 diabetes will be included in the study.

Design: Cohort Study Intervention: 12 weeks intervention period consisting of aerobic exercise training 3 sessions/week, 45 min/session. All training sessions are supervised. Aerobic training is conducted as ergometer bicycle training at an intensity of 70% of maximal oxygen uptake (x2/wk.) and rowing ergometer exercise at 70% of maximal heart rate (x1/wk.). In week 3, 6 and 9 VO2max is measured to ensure sufficient adjustment of the workload during the training sessions.

Experimental methods: Before (1-2 weeks) and after the intervention, the following tests and measurements are performed:

Day A: (Overnight fasting. Duration approx. 3 h)

* Dual energy x-ray absorptiometry (DXA) scan (body composition and body fat)
* Graded exercise test on an ergometer bike (maximal fat oxidation rate)
* Maximal oxygen consumption test (VO2max)
* Handgrip strength (by dynamometer)
* Leg power (Power Rig and sit-to-stand test)

Day B: (Overnight fasting. Duration approx. 9 h)

* 2-step euglycemic, hyperinsulinemic clamp
* Muscle biopsy vastus lateralis
* Fat biopsy subcutaneous lower abdomen
* Flow measurements (Femoral artery by Doppler ultrasound and forearm by strain-gauge plethysmography)
* Energy expenditure (ventilated hood method)

Day A and B are repeated after the training intervention has finished.

Analytical methods:

1. Muscle and fat biopsies: Mitochondrial respiratory capacity and reactive oxygen species production. Single nuclei RNA sequencing (snSeq). Fiber type determination and capillarization.
2. Blood samples: Hormones, metabolites and substrates (e.g. insulin, catecholamines, cortisol, glucose, lactate, pyruvate, ketone bodies, cytokines, and myokines). Plasma proteomic/peptidomic analysis.

In summary, this study will reveal cell types and genes in skeletal muscle and adipose tissue that are affected by training and/or that shows differential regulation in patients with T2D versus control subjects.

Statistical considerations:

A power calculation indicates that a significant difference in training induced insulin sensitivity will be detectable when n ≥ 10, based on power = 0.95 and level of significance set to P\<0.05. This allows for a dropout rate of a 15-20% with some margin. Mixed model analysis will be used for data analysis of phenotypical data, and bioinformatical tools for the snSeq data and for the interaction between gene- and phenotype expression.

Ethical considerations:

The project was approved by The Regional Ethical Committee of the Capital Region (H-20046605) the 15th of December 2020.

Eligibility criteria: Inclusion Criteria:

* Overweight to obese (BMI 28-35 kg/m2)
* Normal resting ECG

Specific for patients with T2D:

* In antiglycemic treatment with diet +/- metformin, SLGT-2 inhibitors, sulfonylurea, GLP1-RA, or DPPV-4 inhibitors
* Time since diagnosis max 4 yrs

Exclusion Criteria:

* Diagnosed with cardiovascular disease (minor to moderate hypertension allowed, defined as prescribed maximally two different antihypertensive drugs)
* Epilepsy
* Kidney disease (GFR\<50 ml/min)
* Regular exercise activity
* Inability to perform bicycling and rowing ergometer exercise
* Inability to understand Danish language (written and spoken)

Specific for patients with T2D:

- Insulin treatment

Primary outcomes:
measure: Insulin sensitivity
timeFrame: Change from baseline at 12 weeks
measure: Blood flow
timeFrame: Change from baseline at 12 weeks
measure: Gene expression will be quantitatively determined at cellular resolution using single nuclei sequencing
timeFrame: Change from baseline at 12 weeks
Secondary outcomes:
measure: Glucose homeostasis
timeFrame: Change from baseline at 12 weeks
measure: Cardiorespiratory fitness
timeFrame: Baseline and after 3, 6, 9 and 12 weeks of aerobic exercise training
Other outcomes:
Locations:
city: Copenhagen
country: Denmark
facility: Xlab, Faculty of Health and Medical Sciences, University of Copenhagen
Study officials:
affiliation: University of Copenhagen
name: Flemming Dela, MD, DMSc
role: PRINCIPAL_INVESTIGATOR
References: